Solid Biosciences   Report issue

For profit Phase 2
Founded: Cambridge MA United States (2013)

Organization Overview

First Clinical Trial
2017
NCT03368742
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Solid Biosciences | Solid Biosciences, LLC